CorMedix (CRMD) Change in Accured Expenses (2010 - 2025)

CorMedix (CRMD) has 16 years of Change in Accured Expenses data on file, last reported at $52.3 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Accured Expenses rose 248.94% year-over-year to $52.3 million; the trailing twelve-month figure through Dec 2025 stood at $100.8 million (up 338.42% YoY), and the FY2025 full-year result was $100.8 million, up 338.42% from the prior year.
• Change in Accured Expenses declined to $52.3 million in Q4 2025, from $54.7 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $54.7 million in Q3 2025 to a low of -$6.6 million in Q2 2025.
• A 5-year average of $6.4 million and a median of $584721.5 in 2021 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses soared 2917.47% in 2022 and plunged 723.09% in 2025, its largest moves.
• Tracing CRMD's Change in Accured Expenses over 5 years: stood at -$28656.0 in 2021, then soared by 2917.47% to $807375.0 in 2022, then jumped by 126.72% to $1.8 million in 2023, then surged by 718.48% to $15.0 million in 2024, then jumped by 248.94% to $52.3 million in 2025.
• Business Quant data shows CRMD's Change in Accured Expenses at $52.3 million in Q4 2025, $54.7 million in Q3 2025, and -$6.6 million in Q2 2025.